AI assistant
SURMODICS INC — Director's Dealing 2014
Dec 31, 2014
32845_dirs_2014-12-31_4a1e395a-8d4d-42b0-9a33-6518980fed35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2014-12-08
Reporting Person: OLSON CHARLES W (Senior VP & GM, Med Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-08 | Common Stock | S | 3365 | $21.66 | Disposed | 31108 | Direct |
| 2014-12-29 | Common Stock | S | 1718 | $22.60 | Disposed | 29390 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 800 | Indirect |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2014.
F2: Reflects the weighted average price of 1,718 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 29, 2014 with sale prices ranging from $22.541 to $22.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.